EARLY DIAGNOSIS, TREATMENT, AND PREVENTIVE STRATEGIES IN GYNECOLOGIC ONCOLOGY: AN ANALYTICAL REVIEW
Keywords:
Gynecologic oncology, early diagnosis, cervical cancer, ovarian cancer, HPV vaccination, prevention, treatment.Abstract
Gynecologic cancers, including cervical, ovarian, endometrial, vulvar, and vaginal malignancies, represent a major global health burden among women. Early detection and timely intervention are critical to improving survival rates and quality of life. This paper analyzes current approaches to early diagnosis, treatment modalities, and preventive strategies in gynecologic oncology. Screening programs such as Pap smear and HPV testing remain the gold standard for cervical cancer detection, while imaging techniques and biomarker research are expanding opportunities for early ovarian and endometrial cancer identification. Treatment strategies range from surgery and radiotherapy to targeted therapy and immunotherapy, with personalized medicine gaining increasing relevance. Preventive measures, including HPV vaccination, genetic counseling, and lifestyle modifications, are crucial in reducing the incidence of these malignancies. The analysis underscores the need for multidisciplinary management, patient education, and health policy interventions to enhance outcomes
References
Bizzarri, N., & others. (2024). Prophylactic HPV vaccination in HPV-related gynecologic cancers: current evidence and gaps. International Journal of Gynecology & Obstetrics. Advance online publication. PubMed
Cho, H. W., et al. (2021). Updated clinical guideline for human papillomavirus vaccine. European Journal of Gynaecological Oncology. JGO Journal of Gynecologic Oncology
González-Rodríguez, J. C., et al. (2024). Cervical cancer prevention by vaccination: review. Frontiers in Oncology. Frontiers
Massad, L. S. (2009). The impact of human papillomavirus vaccination on gynecologic oncology. Gynecologic Oncology. Society of Gynecologic Oncology
Venturelli, F., & Multisociety Italian Guidelines Working Group. (2021). HPV vaccination in women treated for Cervical Intraepithelial Neoplasia grade 2 or 3: evidence-based recommendation. European Journal of Gynaecological Oncology, 42(5), 1039-1047. Ejgo
Schneiter, M. K., et al. (2022). Gynecologic oncology HPV vaccination practice patterns: survey among gynecologic oncologists. PMC (open access). PMC
Human Papillomavirus Vaccination Committee Opinion. (2020). Human papillomavirus vaccines: recommendations and efficacy. ACOG. Acog
Okhuhara, T., Okada, H., Goto, E., & Kiuchi, T. (2021). Readability assessment of HPV vaccination and cervical cancer information: a systematic scoping review. Healthcare, 9(10), 1246. https://doi.org/10.3390/healthcare9101246 MDPI
Updated clinical guideline for human papillomavirus vaccine. (2021). European Journal of Gynaecological Oncology. JGO Journal of Gynecologic Oncology
Adjuvant human papillomavirus vaccination for patients undergoing treatment for cervical intraepithelial neoplasia. (2023). ACOG Practice Advisory. Acog
